Appointment of a Chief Business officer for Signia Therapeutics It is with a great pleasure that Signia Therapeutics announces the arrival of Frédéric Galli as Chief Business Officer (CBO). Frederic has 30+ years of experience in the pharmaceutical industry, notably at Sanofi, during which he has held numerous positions, from research at the bench (including … Continue reading Appointment of a Chief Business officer for Signia Therapeutics